COVID-19

News

scientifically visualization of a coronavirus spike protein

EMA starts review of GSK/Vir COVID-19 antibody

The EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech's COVID-19 antibody VIR-7831, which could become the fourth drug of its type cleared for earl

News

Risk of brain clots higher with COVID than vaccine, study su...

A study has suggested that the risk of getting a serious brain clot is eight to 10 times higher in people with COVID-19 than those who get a vaccine.

News

Czech Republic swoops for Denmark's 2.4m unwanted AZ COVID s...

The Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, which has said it will stop using it because of concerns about rare

News

Romark eyes FDA okay for COVID antiviral despite mixed trial...

A phase 3 trial of Romark's antiviral drug NT-300 has missed the main objective in a phase 3 trial in mild to moderate COVID-19 patients, but could still have a shot at emergency use author

News

England begins Moderna vaccine rollout as lockdown eases

England is beginning its rollout of the Moderna COVID-19 vaccine, offering an alternative to the AstraZeneca/Oxford University jab following a potential link to a very rare kind of blood cl

News

Update: J&J COVID vaccine rollout paused as clot concerns sp...

US health authorities have recommended pausing dosing with Johnson & Johnson's COVID-19 vaccine as they investigate cases of blood clots also observed in some people taking the AstraZen

EMA starts review of GSK/Vir COVID-19 antibody

Risk of brain clots higher with COVID than vaccine, study su...

Czech Republic swoops for Denmark's 2.4m unwanted AZ COVID s...

Romark eyes FDA okay for COVID antiviral despite mixed trial...

England begins Moderna vaccine rollout as lockdown eases

Update: J&J COVID vaccine rollout paused as clot concerns sp...

Roivant wins FDA approval for first targeted dermatomyositis...

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks